iRhythm Technologies, Inc. financial data

Symbol
IRTC on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
699 8 Th Street, Suite 600, San Francisco, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 453 % +45.4%
Quick Ratio 14.3 % -18.5%
Debt-to-equity 425 % +382%
Return On Equity -107 % -150%
Return On Assets -19.5 % +14.6%
Operating Margin -23.8 % -7.49%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31.2M shares +2.15%
Common Stock, Shares, Outstanding 31.2M shares +2.16%
Entity Public Float 3.2B USD 0%
Common Stock, Value, Issued 31K USD +3.33%
Weighted Average Number of Shares Outstanding, Basic 31.1M shares +2.11%
Weighted Average Number of Shares Outstanding, Diluted 31.1M shares +2.11%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 537M USD +18.8%
Cost of Revenue 176M USD +25.4%
Research and Development Expense 68.4M USD +30%
Operating Income (Loss) -128M USD -27.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -131M USD -32.6%
Income Tax Expense (Benefit) 676K USD +38.2%
Net Income (Loss) Attributable to Parent -132M USD -32.6%
Earnings Per Share, Basic -4.26 USD/shares -30.3%
Earnings Per Share, Diluted -4.26 USD/shares -30.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 551M USD +794%
Marketable Securities, Current 10.9M USD -89.4%
Cash, Cash Equivalents, and Short-term Investments 75.8M USD -42.4%
Accounts Receivable, after Allowance for Credit Loss, Current 85.5M USD +67.3%
Inventory, Net 15.4M USD +6.54%
Assets, Current 678M USD +180%
Property, Plant and Equipment, Net 118M USD +30.9%
Operating Lease, Right-of-Use Asset 46.8M USD -19.1%
Goodwill 862K USD 0%
Other Assets, Noncurrent 68.1M USD +75.7%
Assets 919M USD +114%
Accounts Payable, Current 13.4M USD +87.8%
Accrued Liabilities, Current 65.9M USD +2.28%
Contract with Customer, Liability, Current 3.15M USD -14.9%
Liabilities, Current 97.9M USD +9.49%
Operating Lease, Liability, Noncurrent 76.2M USD -5.06%
Other Liabilities, Noncurrent 940K USD -7.12%
Liabilities 820M USD +299%
Accumulated Other Comprehensive Income (Loss), Net of Tax 182K USD
Retained Earnings (Accumulated Deficit) -711M USD -22.7%
Stockholders' Equity Attributable to Parent 99.2M USD -55.7%
Liabilities and Equity 919M USD +114%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -52M USD -69.2%
Net Cash Provided by (Used in) Financing Activities 505M USD +55661%
Net Cash Provided by (Used in) Investing Activities 40M USD +947%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 31.4M shares +2.91%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 493M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 559M USD +808%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.6M USD +135%
Deferred Tax Assets, Valuation Allowance 218M USD +15.8%
Deferred Tax Assets, Gross 230M USD +8.28%
Operating Lease, Liability 91.6M USD -2.94%
Payments to Acquire Property, Plant, and Equipment 9.78M USD +16.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -131M USD -32.8%
Lessee, Operating Lease, Liability, to be Paid 119M USD -6.37%
Property, Plant and Equipment, Gross 178M USD +35%
Operating Lease, Liability, Current 15.4M USD +9.11%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.1M USD -21.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 15.6M USD -24.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 27.7M USD -16.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.5M USD -18.2%
Deferred Tax Assets, Operating Loss Carryforwards 128M USD +14.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 5.77M USD +22%
Lessee, Operating Lease, Liability, to be Paid, Year Four 16.4M USD -17.1%
Operating Lease, Payments 3.2M USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 19.2M USD +34.3%
Deferred Tax Assets, Net of Valuation Allowance 12.1M USD -50.1%
Share-based Payment Arrangement, Expense 87.7M USD +43.5%
Interest Expense 5.56M USD +81.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%